Probiotics VSL#3 protect against development of visceral pain in murine model of irritable bowel syndrome

scientific article

Probiotics VSL#3 protect against development of visceral pain in murine model of irritable bowel syndrome is …
instance of (P31):
scholarly articleQ13442814

External links are
P819ADS bibcode2013PLoSO...863893D
P356DOI10.1371/JOURNAL.PONE.0063893
P932PMC publication ID3655059
P698PubMed publication ID23691109
P5875ResearchGate publication ID236925283

P50authorBarbara RengaQ114572165
Sabrina CiprianiQ114572169
P2093author name stringAndrea Mencarelli
Stefano Fiorucci
Eleonora Distrutti
P2860cites workNCBI GEO: archive for functional genomics data sets--10 years onQ24610731
Functional bowel disorders and functional abdominal painQ24675171
Probiotics modulate intestinal expression of nuclear receptor and provide counter-regulatory signals to inflammation-driven adipose tissue activationQ27327276
Gene Expression Omnibus: NCBI gene expression and hybridization array data repositoryQ27860523
Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis.Q30581062
The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjectsQ33290848
A randomized controlled trial of a probiotic combination VSL# 3 and placebo in irritable bowel syndrome with bloatingQ33434046
Dose-dependent immunomodulation of human dendritic cells by the probiotic Lactobacillus rhamnosus Lcr35.Q33886503
Serotonin signaling is altered in irritable bowel syndrome with diarrhea but not in functional dyspepsia in pediatric age patients.Q33987389
Stress-related modulation of inflammation in experimental models of bowel disease and post-infectious irritable bowel syndrome: role of corticotropin-releasing factor receptorsQ34231605
VSL#3 resets insulin signaling and protects against NASH and atherosclerosis in a model of genetic dyslipidemia and intestinal inflammationQ34428997
Maternal deprivation affects the neuromuscular protein profile of the rat colon in response to an acute stressor later in lifeQ57567017
VSL#3 Probiotic-Mixture Induces Remission in Patients with Active Ulcerative ColitisQ59120549
5-Amino-2-hydroxybenzoic Acid 4-(5-Thioxo-5H-[1,2]dithiol-3yl)-phenyl Ester (ATB-429), a Hydrogen Sulfide-Releasing Derivative of Mesalamine, Exerts Antinociceptive Effects in a Model of Postinflammatory HypersensitivityQ60695409
A new model of chronic visceral hypersensitivity in adult rats induced by colon irritation during postnatal developmentQ73130772
Serotonin synthesis and uptake in symptomatic patients with Crohn's disease in remissionQ80270928
Lactobacillus reuteri ingestion prevents hyperexcitability of colonic DRG neurons induced by noxious stimuliQ83264605
Effects of Bifidobacterium breve on inflammatory gene expression in neonatal and weaning rat intestineQ83363194
Probiotics in man and animalsQ34505006
Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trialQ34510060
Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitisQ35596222
Neonatal maternal deprivation triggers long term alterations in colonic epithelial barrier and mucosal immunity in rats.Q35596401
The emerging roles of hydrogen sulfide in the gastrointestinal tract and liverQ36532353
The tryptophan hydroxylase inhibitor LX1031 shows clinical benefit in patients with nonconstipating irritable bowel syndromeQ36998938
Is irritable bowel syndrome an inflammatory disorder?Q37216854
Development of nociceptin receptor (NOP) agonists and antagonistsQ37680813
Recently patented and promising ORL-1 ligands: where have we been and where are we going?Q37697788
Cannabinoid 1 (CB1) receptor--pharmacology, role in pain and recent developments in emerging CB1 agonistsQ37883405
Pharmacotherapy for acute pouchitisQ37903194
Visceral pain: a review of experimental studiesQ37939840
VSL#3 improves symptoms in children with irritable bowel syndrome: a multicenter, randomized, placebo-controlled, double-blind, crossover studyQ39286213
A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndromeQ39396709
Hydrogen sulphide induces micro opioid receptor-dependent analgesia in a rodent model of visceral painQ39694347
Unbalanced expression of protease-activated receptors-1 and -2 in the colon of diarrhea-predominant irritable bowel syndrome patientsQ39980879
Probiotic Lactobacillus reuteri suppress proinflammatory cytokines via c-JunQ40100857
Basic and clinical aspects of visceral hyperalgesiaQ40666271
The effects of early rearing environment on the development of GABAA and central benzodiazepine receptor levels and novelty-induced fearfulness in the rat.Q42620039
Neonatal maternal separation in the rat impacts on the stress responsivity of central corticotropin-releasing factor receptors in adulthoodQ42661715
The probiotic Bifidobacterium infantis 35624 displays visceral antinociceptive effects in the rat.Q42662550
Effects of the probiotic Bifidobacterium infantis in the maternal separation model of depressionQ42942477
Rectal function and bowel habit in irritable bowel syndromeQ43307195
Neonatal maternal separation alters stress-induced responses to viscerosomatic nociceptive stimuli in rat.Q43350989
Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trialQ43363077
Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptorsQ44333170
A nitro-arginine derivative of trimebutine (NO2-Arg-Trim) attenuates pain induced by colorectal distension in conscious rats.Q46024960
Evidence that hydrogen sulfide exerts antinociceptive effects in the gastrointestinal tract by activating KATP channelsQ46726610
Neonatal maternal separation causes colonic dysfunction in rat pups including impaired host resistanceQ46834985
Maternal separation alters serotonergic transporter densities and serotonergic 1A receptors in rat brainQ46986227
Neonatal maternal separation enhances central sensitivity to noxious colorectal distention in rat.Q48202749
Both long and brief maternal separation produces persistent changes in tissue levels of brain monoamines in middle-aged female ratsQ48310651
Effects of neonatal maternal separation on neurochemical and sensory response to colonic distension in a rat model of irritable bowel syndrome.Q48367744
Maternal separation in neonatal rats elicits activation of the hypothalamic-pituitary-adrenocortical axis: a putative role for corticotropin-releasing factorQ48379128
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P4510describes a project that usesCytoscapeQ3699942
P433issue5
P407language of work or nameEnglishQ1860
P921main subjectirritable bowel syndromeQ838966
probioticsQ1816730
murine modelQ122890741
P304page(s)e63893
P577publication date2013-05-15
P1433published inPLOS OneQ564954
P1476titleProbiotics VSL#3 protect against development of visceral pain in murine model of irritable bowel syndrome
P478volume8

Reverse relations

cites work (P2860)
Q36179096Administration of a Multi-Strain Probiotic Product to Women in the Perinatal Period Differentially Affects the Breast Milk Cytokine Profile and May Have Beneficial Effects on Neonatal Gastrointestinal Functional Symptoms. A Randomized Clinical Trial
Q35534031Alterations in serotonin, transient receptor potential channels and protease-activated receptors in rats with irritable bowel syndrome attenuated by Shugan decoction
Q38376282Animal models of gastrointestinal and liver diseases. Animal models of visceral pain: pathophysiology, translational relevance, and challenges
Q35532177Antibiotic-induced dysbiosis alters host-bacterial interactions and leads to colonic sensory and motor changes in mice.
Q35111263Are there any different effects of Bifidobacterium, Lactobacillus and Streptococcus on intestinal sensation, barrier function and intestinal immunity in PI-IBS mouse model?
Q36875133Bifidobacterium animalis ssp. lactis CNCM-I2494 Restores Gut Barrier Permeability in Chronically Low-Grade Inflamed Mice
Q37564174Chronic Early-life Stress in Rat Pups Alters Basal Corticosterone, Intestinal Permeability, and Fecal Microbiota at Weaning: Influence of Sex.
Q100491009Disruption of Firmicutes and Actinobacteria abundance in tomato rhizosphere causes the incidence of bacterial wilt disease
Q64257546Divergent Effectiveness of Multispecies Probiotic Preparations on Intestinal Microbiota Structure Depends on Metabolic Properties
Q55612911Dynamic changes in morphology, gene expression and microbiome in the jejunum of compensatory-growth rats induced by protein restriction.
Q35586987Efficacy of combination therapy with probiotics and mosapride in patients with IBS without diarrhea: a randomized, double-blind, placebo-controlled, multicenter, phase II trial.
Q36816915Gut Microbiome: What We Do and Don't Know
Q28081092Gut Microbiota: A Modulator of Brain Plasticity and Cognitive Function in Ageing
Q26768550Gut microbiota role in irritable bowel syndrome: New therapeutic strategies
Q55190074Heat shock protein 70 protects mouse against post-infection irritable bowel syndrome via up-regulating intestinal γδ T cell's Th17 response.
Q42268439Host-probiotic interaction: new insight into the role of the endocannabinoid system by in vivo and ex vivo approaches
Q48291685Immune response of patients with recurrent aphthous stomatitis challenged with a symbiotic
Q36191384Lactobacillus rhamnosus CNCM I-3690 and the commensal bacterium Faecalibacterium prausnitzii A2-165 exhibit similar protective effects to induced barrier hyper-permeability in mice
Q93097689Maternal separation in rodents: a journey from gut to brain and nutritional perspectives
Q41159790Metabolic Variability of a Multispecies Probiotic Preparation Impacts on the Anti-inflammatory Activity.
Q42098016Microbiota modulation counteracts Alzheimer's disease progression influencing neuronal proteolysis and gut hormones plasma levels.
Q90269186Microbiota: a novel regulator of pain
Q34499067Modulation of immunity and inflammatory gene expression in the gut, in inflammatory diseases of the gut and in the liver by probiotics
Q34155897Modulation of intestinal microbiota by the probiotic VSL#3 resets brain gene expression and ameliorates the age-related deficit in LTP
Q48313903Oral probiotic treatment of Lactobacillus rhamnosus Lcr35® prevents visceral hypersensitivity to a colonic inflammation and an acute psychological stress.
Q94527883Probiotic mixture VSL#3: An overview of basic and clinical studies in chronic diseases
Q27322790Spatial Localization and Binding of the Probiotic Lactobacillus farciminis to the Rat Intestinal Mucosa: Influence of Chronic Stress
Q35867820Stress and the Microbiota-Gut-Brain Axis in Visceral Pain: Relevance to Irritable Bowel Syndrome
Q35087100Stress-induced visceral pain: toward animal models of irritable-bowel syndrome and associated comorbidities
Q90705702Systematic review and meta-analysis: Efficacy of patented probiotic, VSL#3, in irritable bowel syndrome
Q46438777The Role of the Gastrointestinal Microbiota in Visceral Pain
Q30415125The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems
Q34129427The microbiota-gut-brain axis in functional gastrointestinal disorders
Q35155407The microbiota-gut-brain axis in gastrointestinal disorders: stressed bugs, stressed brain or both?
Q35931334The potential influence of the microbiota and probiotics on women during long spaceflights
Q26739291The role of visceral hypersensitivity in irritable bowel syndrome: pharmacological targets and novel treatments
Q36140404VSL#3 induces and maintains short-term clinical response in patients with active microscopic colitis: a two-phase randomised clinical trial
Q57476129Visceral pain: gut microbiota, a new hope?

Search more.